Literature DB >> 7510329

Lentivirus cross-reactive determinants present in the capsid protein of equine infectious anaemia virus.

C H Grund1, E R Lechman, C J Issel, R C Montelaro, K E Rushlow.   

Abstract

In this study we used immune sera from equine infectious anaemia virus (EIAV)-infected horses which uniquely display broad reactivity with different lentivirus capsid proteins (CA) to characterize the cross-reactive determinants of lentivirus CA proteins. In particular, the role of the major homology region (MHR) of lentivirus CA proteins in this serological cross-reactivity was evaluated using both equine immune serum and murine monoclonal antibodies (MAbs) directed against the MHR segment of different lentiviruses. The results of our studies indicate that about 80% of sera from long-term experimentally infected ponies or naturally infected horses react with human immunodeficiency virus type 1 CA in Western immunoblot assays. In addition, the cross-reactive determinants on the EIAV CA were localized within the immunodominant carboxyl terminus of the protein (residues 277 to 367). However, the cross-reactive determinants recognized by the equine sera do not appear to correlate with linear peptides from the carboxyl terminus of the EIAV CA, including the MHR. These results suggest cross-reactivity between more distant lentiviruses is associated with non-linear determinants. In contrast, MHR-specific MAbs did react with linear peptides by ELISA and distinguished the primate lentiviruses from EIAV and feline immunodeficiency virus. These data support the concept of a highly conserved structural and antigenic organization among the CA proteins of lentiviruses from different species.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510329     DOI: 10.1099/0022-1317-75-3-657

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

Review 1.  Lymphoid leukosis viruses, their recognition as 'persistent' viruses and comparisons with certain other retroviruses of veterinary importance.

Authors:  C Darcel
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

2.  Envelope variation as a primary determinant of lentiviral vaccine efficacy.

Authors:  Jodi K Craigo; Baoshan Zhang; Shannon Barnes; Tara L Tagmyer; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-10       Impact factor: 11.205

3.  TaqMan real-time reverse transcription-PCR and JDVp26 antigen capture enzyme-linked immunosorbent assay to quantify Jembrana disease virus load during the acute phase of in vivo infection.

Authors:  Meredith Stewart; Moira Desport; Nining Hartaningsih; Graham Wilcox
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines.

Authors:  Jodi K Craigo; Shannon Durkin; Timothy J Sturgeon; Tara Tagmyer; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  Vaccine       Date:  2006-09-22       Impact factor: 3.641

5.  Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus.

Authors:  Jodi K Craigo; Corin Ezzelarab; Ronald C Montelaro
Journal:  J Virol Methods       Date:  2012-07-20       Impact factor: 2.014

6.  Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses.

Authors:  S M Lonning; W Zhang; T C McGuire
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.

Authors:  Jodi K Craigo; Feng Li; Jonathan D Steckbeck; Shannon Durkin; Laryssa Howe; Sheila J Cook; Charles Issel; Ronald C Montelaro
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

8.  Detection of equine infectious anemia viral RNA in plasma samples from recently infected and long-term inapparent carrier animals by PCR.

Authors:  J L Langemeier; S J Cook; R F Cook; K E Rushlow; R C Montelaro; C J Issel
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

9.  Challenges and proposed solutions for more accurate serological diagnosis of equine infectious anaemia.

Authors:  C J Issel; M T Scicluna; S J Cook; R F Cook; A Caprioli; I Ricci; F Rosone; J K Craigo; R C Montelaro; G L Autorino
Journal:  Vet Rec       Date:  2012-11-16       Impact factor: 2.695

10.  Envelope determinants of equine lentiviral vaccine protection.

Authors:  Jodi K Craigo; Corin Ezzelarab; Sheila J Cook; Liu Chong; David Horohov; Charles J Issel; Ronald C Montelaro
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.